Covid-19 Small Molecule Drugs Market, Global Outlook and Forecast 2023-2028

Report ID: 1651412 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Covid-19 Small Molecule Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Targets
        1.2.2 Market by Application
    1.3 Global Covid-19 Small Molecule Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Covid-19 Small Molecule Drugs Overall Market Size
    2.1 Global Covid-19 Small Molecule Drugs Market Size: 2021 VS 2028
    2.2 Global Covid-19 Small Molecule Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Covid-19 Small Molecule Drugs Players in Global Market
    3.2 Top Global Covid-19 Small Molecule Drugs Companies Ranked by Revenue
    3.3 Global Covid-19 Small Molecule Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Covid-19 Small Molecule Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Covid-19 Small Molecule Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Small Molecule Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Covid-19 Small Molecule Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Covid-19 Small Molecule Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Targets - Global Covid-19 Small Molecule Drugs Market Size Markets, 2021 & 2028
        4.1.2 RdRp
        4.1.3 3CLpro
    4.2 By Targets - Global Covid-19 Small Molecule Drugs Revenue & Forecasts
        4.2.1 By Targets - Global Covid-19 Small Molecule Drugs Revenue, 2017-2022
        4.2.2 By Targets - Global Covid-19 Small Molecule Drugs Revenue, 2023-2028
        4.2.3 By Targets - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Covid-19 Small Molecule Drugs Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Scientific Research
    5.2 By Application - Global Covid-19 Small Molecule Drugs Revenue & Forecasts
        5.2.1 By Application - Global Covid-19 Small Molecule Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Covid-19 Small Molecule Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Covid-19 Small Molecule Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Covid-19 Small Molecule Drugs Revenue & Forecasts
        6.2.1 By Region - Global Covid-19 Small Molecule Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Covid-19 Small Molecule Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Covid-19 Small Molecule Drugs Revenue, 2017-2028
        6.3.2 US Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.3.3 Canada Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.3.4 Mexico Covid-19 Small Molecule Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Covid-19 Small Molecule Drugs Revenue, 2017-2028
        6.4.2 Germany Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.4.3 France Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.4.4 U.K. Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.4.5 Italy Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.4.6 Russia Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.4.8 Benelux Covid-19 Small Molecule Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Covid-19 Small Molecule Drugs Revenue, 2017-2028
        6.5.2 China Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.5.3 Japan Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.5.4 South Korea Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.5.6 India Covid-19 Small Molecule Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Covid-19 Small Molecule Drugs Revenue, 2017-2028
        6.6.2 Brazil Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.6.3 Argentina Covid-19 Small Molecule Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue, 2017-2028
        6.7.2 Turkey Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.7.3 Israel Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Covid-19 Small Molecule Drugs Market Size, 2017-2028
        6.7.5 UAE Covid-19 Small Molecule Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Shanghai Junshi biosciences
        7.1.1 Shanghai Junshi biosciences Corporate Summary
        7.1.2 Shanghai Junshi biosciences Business Overview
        7.1.3 Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Major Product Offerings
        7.1.4 Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
        7.1.5 Shanghai Junshi biosciences Key News
    7.2 Ascletis Pharma
        7.2.1 Ascletis Pharma Corporate Summary
        7.2.2 Ascletis Pharma Business Overview
        7.2.3 Ascletis Pharma Covid-19 Small Molecule Drugs Major Product Offerings
        7.2.4 Ascletis Pharma Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
        7.2.5 Ascletis Pharma Key News
    7.3 Merck and Co (MSD)
        7.3.1 Merck and Co (MSD) Corporate Summary
        7.3.2 Merck and Co (MSD) Business Overview
        7.3.3 Merck and Co (MSD) Covid-19 Small Molecule Drugs Major Product Offerings
        7.3.4 Merck and Co (MSD) Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
        7.3.5 Merck and Co (MSD) Key News
    7.4 Pfizer
        7.4.1 Pfizer Corporate Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Covid-19 Small Molecule Drugs Major Product Offerings
        7.4.4 Pfizer Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
        7.4.5 Pfizer Key News
    7.5 Shionogi
        7.5.1 Shionogi Corporate Summary
        7.5.2 Shionogi Business Overview
        7.5.3 Shionogi Covid-19 Small Molecule Drugs Major Product Offerings
        7.5.4 Shionogi Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
        7.5.5 Shionogi Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Covid-19 Small Molecule Drugs Market Opportunities & Trends in Global Market
    Table 2. Covid-19 Small Molecule Drugs Market Drivers in Global Market
    Table 3. Covid-19 Small Molecule Drugs Market Restraints in Global Market
    Table 4. Key Players of Covid-19 Small Molecule Drugs in Global Market
    Table 5. Top Covid-19 Small Molecule Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Covid-19 Small Molecule Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Covid-19 Small Molecule Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Covid-19 Small Molecule Drugs Product Type
    Table 9. List of Global Tier 1 Covid-19 Small Molecule Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Covid-19 Small Molecule Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Targets – Global Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Targets - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Targets - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Covid-19 Small Molecule Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Covid-19 Small Molecule Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Shanghai Junshi biosciences Corporate Summary
    Table 31. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Product Offerings
    Table 32. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Ascletis Pharma Corporate Summary
    Table 34. Ascletis Pharma Covid-19 Small Molecule Drugs Product Offerings
    Table 35. Ascletis Pharma Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Merck and Co (MSD) Corporate Summary
    Table 37. Merck and Co (MSD) Covid-19 Small Molecule Drugs Product Offerings
    Table 38. Merck and Co (MSD) Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Covid-19 Small Molecule Drugs Product Offerings
    Table 41. Pfizer Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Shionogi Corporate Summary
    Table 43. Shionogi Covid-19 Small Molecule Drugs Product Offerings
    Table 44. Shionogi Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Covid-19 Small Molecule Drugs Segment by Targets in 2021
    Figure 2. Covid-19 Small Molecule Drugs Segment by Application in 2021
    Figure 3. Global Covid-19 Small Molecule Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Covid-19 Small Molecule Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Covid-19 Small Molecule Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Covid-19 Small Molecule Drugs Revenue in 2021
    Figure 8. By Targets - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 12. US Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 24. China Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Ascletis Pharma Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Merck and Co (MSD) Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Shionogi Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
60
Frequently Asked Questions
Covid-19 Small Molecule Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Covid-19 Small Molecule Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Covid-19 Small Molecule Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports